Viela Bio, Inc. Rings the Opening Bell in Celebration of its IPO
ABOUT THIS EVENT
Viela Bio, Inc. (Nasdaq: VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, visited the Nasdaq MarketSite in Times Square.
In honor of its Initial Public Offering, Bing Yao, Ph.D., Chairman & Chief Executive Officer, rang the Opening Bell.